1. Home
  2. PKOH vs HUMA Comparison

PKOH vs HUMA Comparison

Compare PKOH & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park-Ohio Holdings Corp.

PKOH

Park-Ohio Holdings Corp.

HOLD

Current Price

$21.21

Market Cap

283.3M

Sector

Industrials

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.36

Market Cap

324.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKOH
HUMA
Founded
1907
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
283.3M
324.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PKOH
HUMA
Price
$21.21
$1.36
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$10.13
AVG Volume (30 Days)
32.9K
5.0M
Earning Date
11-05-2025
11-12-2025
Dividend Yield
2.42%
N/A
EPS Growth
30.26
N/A
EPS
1.68
N/A
Revenue
$1,592,500,000.00
$1,571,000.00
Revenue This Year
$0.23
N/A
Revenue Next Year
$3.07
$1,468.13
P/E Ratio
$9.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.52
$1.09
52 Week High
$33.19
$6.77

Technical Indicators

Market Signals
Indicator
PKOH
HUMA
Relative Strength Index (RSI) 60.73 47.79
Support Level $18.69 $1.09
Resistance Level $20.50 $1.26
Average True Range (ATR) 0.74 0.11
MACD 0.19 0.03
Stochastic Oscillator 98.20 76.50

Price Performance

Historical Comparison
PKOH
HUMA

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: